Receptol is a concentrated extract (using a proprietary/ patented method ) of bovine (cow) colostrum.
The product is a very effective antiviral delivered in a spray form that is well tolerated with a range of use from the very young to old for any viral illness. Its effectiveness has been been demonstrated in several trials totalling 25,000 people. (See below Meta Analysis Data and Receptol Research/ Trials in Menu)
How does Receptol work?
The product Receptol contains two different groups of compounds that are the smallest in colostrum. These two compounds are small enough to be easily absorbed as a mouth spray. As a result the compounds pass directly into the bloodstream undamaged by digestion.
The compounds are small proteins called peptides which in this case act as signaling molecules for our immune system. (In Receptol the peptides are called PRP’s and another called Radha 8 nano information peptides.)
These peptides directly signal our body to fight viruses, and will also balance an immune system which is overactive ( such as in autoimmune conditions.) They also have a direct immune effect by physically stopping the binding of viruses to host cells.
Patents
U.S. Patent No. 9,249,188 on February 02, 2016 & US product Patent US 8,518,454 B
The mammalian colostrum derived nano peptides for broad-spectrum viral and recurrent infections along with 58 approved indications by US PTO with a method of isolation thereof, Patented product with U.S. Patent No. 9,249,188 on February 02, 2016 & US product Patent US 8,518,454 B2; South Africa Patent # 2011/04687; European Patent Application #. 09827010.1. Patent Information.
Clinical data : Early phase studies were conducted in Africa in patients with HIV infection and at Ohio US. (HIV Study Reports: Africa1, Africa2, India1, India2, USA - Ohio). Phase-III accelerated clinical trial was conducted in India to study the effect of Receptol® in patients with HIV / AIDS as a model for totally Immune compromised patients.
(CTRI Registration No.: CTRI/2012/08/002931). In summary, there was significant reduction in viral load & resolution of clinical symptoms of diarrhea, fever, cough, and chronic fatigue syndrome; there was a significant increase in CD4 count accompanied by a significant increase in body weight. No deaths or any adverse safety signal was reported (Study Report).
Receptol® a new generation therapeutic drug and vaccine is derived from Bovine Colostrum’s Proline-rich Polypeptides and RADHA (108) Nanopeptide extract produced through a patented technology is a highly effective and safe drug for patients with reduced immune functions. While patents have been obtained for use in 58 indications. The drug is as an immunity enhancer for immune illnesses.
Receptol is well tolerated with no adverse effects.
Moreover, growth factors contained in colostrum, particularly insulin-like growth factor 1 (IGF-1), play a central role in controlling metabolism. IGF-1 is involved in regulating cell growth and repair and impact on our body's overall energy consumption.
Clinical Trial Results
Manufacturing Process
1) Collection of raw colostrum: Colostrum is collected and stored at -20C.
2) Colostrum whey processing: Raw colostrum stored at -20C is processed under control propriety conditions to generate colostrum whey.
3) Pre-filtration of colostrum whey: The colostrum whey is subjected to pre-filtration through a seriesof micron filters at low pressure. The obtained permeate is checked for critical parameters and analyzed.
4) Ultra Filtration (UF) I: The permeate obtained after pre-filtration is subjected to UF I through seriesof ultra-filters at low pressure. The obtained permeate is checked for critical parameters and analyzed.
5) Ultra filtration (UF) II: The permeate obtained after UF I is subjected to UF II through series of ultrafilters at low pressure. The obtained permeate is checked for critical parameters and analyzed.
6) Bulk manufacturing: The permeate obtained from UF II is added with preservatives. The pH of the bulk is adjusted and flavor is added under continuous stirring. The final bulk is mixed for specified timeprior to final filtration.
7) Final filtration: The manufactured bulk is subjected to absolute biological filters to ensure totalremoval of microorganisms and provides safe liquid containing Proline rich polypeptides containingRadha108 sequences. The obtained permeate is checked for critical parameters and analyzed.
8) Filling, Sealing and storage: The filtered bulk product filled, sealed and stored at room temperature.
I'm a paragraph. Click here to add your own text and edit me. It's easy.